Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch

Clinical trial NCT01416116 · COMPLETED

Trial details

NCT number: NCT01416116
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

or Peripheral Nerve Injury (PNI)Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN)

Start date: 2011-07-06
Primary completion: 2012-04-25
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.